We are excited to launch the Allevi Vascularization Protocol. This method empowers you to replicate some of the most complex vascular trees in an easy way. It enables you to
We’re excited to announce that Allevi joins the Johnson & Johnson JPOD in Philadelphia. As new applications continue to be developed within the Allevi community, we feel the responsibility to
At Allevi, we believe that the democratization of bioprinting can help millions lead longer and healthier lives. By empowering scientists to make complex, relevant, personalized 3D tissues so many breakthroughs will
This new addition to the Allevi Author Club is 3D bioprinting spinal cord… People often ask us, “what is it that a bioprinter can do really well?”, and we tell
The fight to ban cosmetic animal testing recently scored a major victory when California became the first US state to pass a bill that would ban testing cosmetics on animals.
Gelatin Methacrylate (GelMA) is a popular material in bioprinting due to its mechanical properties and printability. The methacrylate groups in this bioink mean that you are able to cure the
Here at Allevi, we are constantly working to make our bioprinters and bioinks accessible to scientists worldwide. Our mission is to get Allevi 3D bioprinters into the best research labs where they
Time for another inductee to the #AlleviAuthor club. Researchers from University of California, Berkeley and IBM used their Allevi 2 bioprinter to study the printability and viability of plant-based bioinks.
Exciting things are happening in the fields of tissue engineering and regenerative medicine. Since our humble beginnings, the Allevi community has grown to labs in all corners of the globe
There are so many variables that go into creating viable 3d bioprinted tissues; bioink selection, print geometry, cure times, rigidity, flexibility, degradation time and cell viability to name a few.
Our amazing users at The University of Waikato will use their Allevi 2 to research new treatment paths for cancer patients that could eventually lead to cancer tumors being treated
In this edition of the #AlleviAuthor series, our very own Director of Bioengineering, Taci Pereira, reviews state of the art bone biofabrication technologies for the Journal of 3D Printing in Medicine.